HIGH CORRELATION OF THE QUANTUM BLUE® RAPID ASSAY WITH HPLC TANDEM MASS SPECTROMETRY FOR INFLIXIMAB THERAPEUTIC DRUG MONITORING
Ryan N. Olson 1
Florian Frei 2
Jennifer Stuart 3
Maria Alice V. Willrich 3
1 Mayo Clinic, Rochester, United States
2 BÜHLMANN Laboratories AG, Schönenbuch, Switzerland
3 BÜHLMANN Diagnostics Corp, Amherst, United States
Session
IBD (Posters)
Conference
UEG Week Virtual 2020
Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]